This trial is active, not recruiting.

Condition blood donor
Treatments text message, telephone
Sponsor Guangzhou Blood Center
Start date November 2015
End date March 2016
Trial size 1188 participants
Trial identifier NCT02646059, GuangzhouBC1


Blood donor recruitment is an important issue in every country, since the blood supply pressure become more and more intense. Donor retention is even more important, because it is easier to recruit an old customers than a new one. Therefore, figuring the most effective ways of recruiting lapsed blood donors and understanding the reasons of not donating blood again is critical and vital for the development of blood donation.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking single blind (subject)
Text messages containing reminds of blood donation information would be sent to donors in this group.
text message
Text messages would be sent via the messaging platform of Guangzhou Blood Center. The feedback of sending status (received, failed to receive, or unknown) would be marked on every number. Four to six months follow-up, blood donation rate would be checked.
Investigators would give telephone calls to the donors in this group, ask the reasons why they stopped donating blood.
Status (response, no answer, line issue, wrong number or refused to be interviewed) of every donor in this groups would be marked. Four to six months follow-up, blood donation rate would be checked.
(No Intervention)
No intervention will be giving to this group.

Primary Outcomes

Blood donaiton rate
time frame: four to six months

Secondary Outcomes

Reasons of not donating again
time frame: 1 months

Eligibility Criteria

Male or female participants from 18 years up to 50 years old.

Inclusion Criteria: - Donated blood at least once between 2009 to 2013, and the blood test result is qualified. Exclusion Criteria: - Having donated again before intervened.

Trial information was received from ClinicalTrials.gov and was last updated in January 2016.
Information provided to ClinicalTrials.gov by Guangzhou Blood Center.